Skip to content
Back Home

Northeast Ohio’s trusted resource for HIV/AIDS Clinical Trials, Primary Care, and World Class Research

Northeast Ohio’s trusted resource for HIV/AIDS Clinical Trials, Primary Care, and World Class Research

  • Home
  • Clinical Trials
    • People Living With HIV
    • COVID-19 Studies
    • Clinical Trials FAQ
  • News
  • Get Involved
    • HIV-Related Clinical Trials
    • Community Links
    • Community Advisory Board
    • Contact
  • Events

All Clinical Trials

tri-specific antibody

Published April 10, 2019 at dimensions 256 × 369 in Trio A5377: A Phase I, first-in-human, ascending-dose study of a tri-specific broadly neutralizing antibody, in participants living with HIV..
https://www.clevelandhiv.org/wp-content/uploads/2019/04/tri-specific-antibody.jpg

Events Calendar

Events in May 2023

MMondayTTuesdayWWednesdayTThursdayFFridaySSaturdaySSunday
1May 1, 2023
2May 2, 2023
3May 3, 2023
4May 4, 2023
5May 5, 2023
6May 6, 2023
7May 7, 2023
8May 8, 2023
9May 9, 2023●(1 event)

Category: ACTU Events 6:00 pm: CAB Meeting (2nd Tuesdays)

6:00 pm – 7:30 pm
May 9, 2023

Read more

10May 10, 2023
11May 11, 2023
12May 12, 2023
13May 13, 2023
14May 14, 2023
15May 15, 2023
16May 16, 2023
17May 17, 2023
18May 18, 2023●(1 event)

Category: ACTU Events N/A: HIV Vaccine Awareness Day

N/A
May 18, 2023

Read more

19May 19, 2023●●(2 events)

Category: ACTU Events N/A: Hepatitis Testing Day

N/A
May 19, 2023

Read more

Category: ACTU Events N/A: National Asian & Pacific Islander HIV/AIDS Awareness Day

N/A
May 19, 2023

Read more

20May 20, 2023
21May 21, 2023
22May 22, 2023
23May 23, 2023
24May 24, 2023
25May 25, 2023
26May 26, 2023
27May 27, 2023
28May 28, 2023
29May 29, 2023
30May 30, 2023
31May 31, 2023
1June 1, 2023
2June 2, 2023
3June 3, 2023
4June 4, 2023
  • Previous
  • Today
  • Next

Events List

  • 6:00 pm – 7:30 pm, June 13, 2023 – CAB Meeting (2nd Tuesdays)
  • N/A, June 27, 2023 – National HIV Testing Day

News

Case Dental gets $3.25M NIH grant to support research in oral health & HIV

July 13, 2022 9:54 pm

$3.25M NIH grant to support research in oral manifestations of... Read more →

A5383: ELICIT clinical trial of anti-CMV medication letermovir

April 22, 2022 6:49 pm

ACTG launches A5383, clinical trial evaluating potential immunologic benefits of... Read more →

Coronavirus FAQ: What does endemic mean — and are we there yet?

March 12, 2022 6:17 am

Has the pandemic moved into the endemic phase? from NPR’s... Read more →

Breakthrough HIV reported in injectable PrEP trial; experts say drug still very effective

February 23, 2022 4:48 pm

Injectable PrEP highly successful, despite HIV infections Experts say breakthrough... Read more →

NIH’s Dr. Carl Dieffenbach Discusses Highlights of HIV Cure, Treatment and Prevention Research from CROI 2022

February 18, 2022 11:14 pm

CROI2022 overview w/Dr. Carl Dieffenbach, head of NIAID NIAID director... Read more →

Contact

Phone: 216-844-4444
Email: info[at]case.edu
More...
Privacy Policy

· © 2023 Cleveland AIDS Clinical Trials Unit · Powered by · Designed with the Customizr theme ·